Uncategorized

Non-Opioid Pain Therapies Get FDA Fast Track: New Guidance Could Reshape Analgesic Development

The FDA just released guidance aimed at accelerating non-opioid pain treatment development, and it could be a game changer for companies working on novel analgesics.

Uncategorized

FDA Shifts COVID Vaccine Strategy to Individual Risk Assessment: The End of Universal Boosters

The CDC’s Advisory Committee on Immunization Practices just voted unanimously to change how we think about COVID vaccination. Instead of universal booster recommendations, they’re now

Healthcare Technology

Ceribell’s IPO Success Marks a Milestone for Portable EEG Technology in Emergency Care

Quick Summary IPO Details: Ceribell launched its IPO at $17 per share, closing above $25. Technology Focus: Portable EEG system for emergency and ICU use.

Uncategorized

Non-Opioid Pain Therapies Get FDA Fast Track: New Guidance Could Reshape Analgesic Development

FDA Shifts COVID Vaccine Strategy to Individual Risk Assessment: The End of Universal Boosters

Ceribell’s IPO Success Marks a Milestone for Portable EEG Technology in Emergency Care

Join a Community of 35,000+ Industry Leaders and Innovators

Stay Ahead in Biotech & MedTech Innovations

Join the BioMed Nexus community and get the latest breakthroughs, research updates, and industry insights delivered straight to your inbox.